The Lundquist Institute
The Lundquist Institute is an engine of innovation with a global reach and a 70-year reputation of improving and saving lives. It focuses on cutting-edge biomedical research, education, and community outreach efforts, aiming to address significant health challenges and enhance patient outcomes.
The Lundquist Institute
1124 W. Carson Street, Torrance, CA 90502
What We Do
The Lundquist Institute is developing a vaccine candidate to combat the drug-resistant fungus Candida auris, which poses a severe health threat. The vaccine has shown effectiveness in preclinical trials and aims to enter human clinical trials soon.
The Lundquist Institute received a $2.6 million grant to develop wearable biosensors for monitoring chronic obstructive pulmonary disease (COPD), aiming to revolutionize disease management.
Awarded a $5.4 million CIRM grant to expand the use of stem cells for modeling human diseases and to enhance research capabilities in underserved communities.
Regenerative Medicine
Key People
Board Member
News & Updates
Join us at Legends 2024 as we celebrate over 70 years of groundbreaking biomedical innovation at The Lundquist Institute and honor our 2024 Legends.
Dr. Shakti Singh has been awarded a five-year NIH grant for groundbreaking research on Candida auris.
The Lundquist Institute's WIC Program received the USDA 2024 WIC Breastfeeding Gold Award of Excellence for outstanding achievement in supporting and promoting breastfeeding.
The Lundquist Institute's WIC Program was recognized for its exemplary efforts in breastfeeding promotion and support.
Dr. Shakti Singh received a prestigious K01 grant to support his research on Candida auris.